{"id":609,"date":"2025-10-09T12:00:47","date_gmt":"2025-10-09T12:00:47","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/10\/09\/zenas-acquires-btk-inhibitor-in-phase-3-trials-for-progressive-ms\/"},"modified":"2025-10-09T12:00:47","modified_gmt":"2025-10-09T12:00:47","slug":"zenas-acquires-btk-inhibitor-in-phase-3-trials-for-progressive-ms","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/10\/09\/zenas-acquires-btk-inhibitor-in-phase-3-trials-for-progressive-ms\/","title":{"rendered":"Zenas acquires BTK inhibitor in Phase 3 trials for progressive MS"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/10\/09\/zenas-acquires-btk-inhibitor-phase-3-trials-progressive-ms\/\" title=\"Zenas acquires BTK inhibitor in Phase 3 trials for progressive MS\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2025\/02\/Handshake2-800x400.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"Two people&#039;s hands are seen clasped together in this close-up view of a handshake.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"146387\" \/><\/a><\/p>\n<p>Zenas Biopharma has acquired global rights to develop the BTK inhibitor orelabrutinib to treat multiple sclerosis (MS) and other diseases. The deal with orelabrutinib&#8217;s developer, Innocare Pharma, includes rights to [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/10\/09\/zenas-acquires-btk-inhibitor-phase-3-trials-progressive-ms\/\">Zenas acquires BTK inhibitor in Phase 3 trials for progressive MS<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/10\/09\/zenas-acquires-btk-inhibitor-phase-3-trials-progressive-ms\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zenas Biopharma has acquired global rights to develop the BTK inhibitor orelabrutinib to treat multiple sclerosis (MS) and other diseases. The deal with orelabrutinib&#8217;s developer, Innocare Pharma, includes rights to [&#8230;] The post Zenas acquires BTK inhibitor in Phase 3 trials for progressive MS appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com<\/p>\n","protected":false},"author":0,"featured_media":610,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-609","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=609"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/609\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/610"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}